|
Maryland
|
|
45-3148087
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification Number)
|
Large accelerated filer
o
|
|
Accelerated filer
x
|
|
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
(Do not check if a smaller reporting company)
|
|
|
Class
|
|
Outstanding at November 1, 2016
|
Common stock, $0.01 par value
|
|
28,482,756
|
|
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of
|
||||||
|
September 30, 2016
|
|
December 31, 2015
|
||||
|
(unaudited)
|
|
|
||||
ASSETS
|
|
|
|
|
|||
Cash and cash equivalents ($10 and $8 related to consolidated VIEs, respectively)
|
$
|
41,768
|
|
|
$
|
5,066
|
|
Restricted cash
|
379
|
|
|
13,083
|
|
||
Loans held for investment ($186,042 and $483,572 related to consolidated VIEs, respectively)
|
1,473,920
|
|
|
1,174,391
|
|
||
Other assets ($1,355 and $2,695 of interest receivable related to consolidated VIEs, respectively; $36,936 and $35,607 of other receivables related to consolidated VIEs, respectively)
|
49,072
|
|
|
53,191
|
|
||
Assets of discontinued operations
|
—
|
|
|
133,251
|
|
||
Total assets
|
$
|
1,565,139
|
|
|
$
|
1,378,982
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
||
LIABILITIES
|
|
|
|
|
|
||
Secured funding agreements
|
$
|
879,102
|
|
|
$
|
522,775
|
|
Secured term loan
|
149,270
|
|
|
69,762
|
|
||
Commercial mortgage-backed securitization debt (consolidated VIE)
|
—
|
|
|
61,815
|
|
||
Collateralized loan obligation securitization debt (consolidated VIE)
|
57,787
|
|
|
192,528
|
|
||
Due to affiliate
|
2,603
|
|
|
2,424
|
|
||
Dividends payable
|
7,406
|
|
|
7,152
|
|
||
Other liabilities ($90 and $299 of interest payable related to consolidated VIEs, respectively)
|
3,703
|
|
|
14,507
|
|
||
Liabilities of discontinued operations
|
—
|
|
|
51,531
|
|
||
Total liabilities
|
1,099,871
|
|
|
922,494
|
|
||
Commitments and contingencies (Note 5)
|
|
|
|
|
|
||
EQUITY
|
|
|
|
|
|
||
Common stock, par value $0.01 per share, 450,000,000 shares authorized at September 30, 2016 and December 31, 2015, 28,482,756 and 28,609,650 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively
|
283
|
|
|
284
|
|
||
Additional paid-in capital
|
419,946
|
|
|
421,179
|
|
||
Accumulated deficit
|
(1,969
|
)
|
|
(11,992
|
)
|
||
Total stockholders' equity
|
418,260
|
|
|
409,471
|
|
||
Non-controlling interests in consolidated VIEs
|
47,008
|
|
|
47,017
|
|
||
Total equity
|
465,268
|
|
|
456,488
|
|
||
Total liabilities and equity
|
$
|
1,565,139
|
|
|
$
|
1,378,982
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
|
(unaudited)
|
|
(unaudited)
|
|
(unaudited)
|
|
(unaudited)
|
||||||||
Net interest margin:
|
|
|
|
|
|
|
|
||||||||
Interest income from loans held for investment
|
$
|
20,776
|
|
|
$
|
20,949
|
|
|
$
|
58,455
|
|
|
$
|
65,131
|
|
Interest expense
|
(9,018
|
)
|
|
(8,707
|
)
|
|
(25,958
|
)
|
|
(27,586
|
)
|
||||
Net interest margin
|
11,758
|
|
|
12,242
|
|
|
32,497
|
|
|
37,545
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
|
|||||||
Management and incentive fees to affiliate
|
1,690
|
|
|
1,351
|
|
|
4,380
|
|
|
4,040
|
|
||||
Professional fees
|
678
|
|
|
617
|
|
|
1,703
|
|
|
1,535
|
|
||||
General and administrative expenses
|
690
|
|
|
698
|
|
|
2,099
|
|
|
2,144
|
|
||||
General and administrative expenses reimbursed to affiliate
|
860
|
|
|
840
|
|
|
2,417
|
|
|
2,591
|
|
||||
Total expenses
|
3,918
|
|
|
3,506
|
|
|
10,599
|
|
|
10,310
|
|
||||
Income from continuing operations before income taxes
|
7,840
|
|
|
8,736
|
|
|
21,898
|
|
|
27,235
|
|
||||
Income tax expense (benefit), including excise tax
|
161
|
|
|
3
|
|
|
168
|
|
|
(15
|
)
|
||||
Net income from continuing operations
|
7,679
|
|
|
8,733
|
|
|
21,730
|
|
|
27,250
|
|
||||
Net income from operations of discontinued operations, net of income taxes
|
1,866
|
|
|
2,977
|
|
|
4,221
|
|
|
5,018
|
|
||||
Gain on sale of discontinued operations
|
10,196
|
|
|
—
|
|
|
10,196
|
|
|
—
|
|
||||
Net income attributable to ACRE
|
19,741
|
|
|
11,710
|
|
|
36,147
|
|
|
32,268
|
|
||||
Less: Net income attributable to non-controlling interests
|
(1,299
|
)
|
|
(2,331
|
)
|
|
(3,876
|
)
|
|
(6,860
|
)
|
||||
Net income attributable to common stockholders
|
$
|
18,442
|
|
|
$
|
9,379
|
|
|
$
|
32,271
|
|
|
$
|
25,408
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Continuing operations
|
$
|
0.22
|
|
|
$
|
0.22
|
|
|
$
|
0.63
|
|
|
$
|
0.72
|
|
Discontinued operations
|
0.42
|
|
|
0.10
|
|
|
0.51
|
|
|
0.18
|
|
||||
Net income
|
$
|
0.65
|
|
|
$
|
0.33
|
|
|
$
|
1.13
|
|
|
$
|
0.89
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Continuing operations
|
$
|
0.22
|
|
|
$
|
0.22
|
|
|
$
|
0.63
|
|
|
$
|
0.71
|
|
Discontinued operations
|
0.42
|
|
|
0.10
|
|
|
0.51
|
|
|
0.18
|
|
||||
Net income
|
$
|
0.65
|
|
|
$
|
0.33
|
|
|
$
|
1.13
|
|
|
$
|
0.89
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
|
|
||||||||
Basic weighted average shares of common stock outstanding
|
28,428,766
|
|
|
28,505,729
|
|
|
28,462,143
|
|
|
28,493,989
|
|
||||
Diluted weighted average shares of common stock outstanding
|
28,513,137
|
|
|
28,609,650
|
|
|
28,536,921
|
|
|
28,593,496
|
|
||||
Dividends declared per share of common stock
|
$
|
0.26
|
|
|
$
|
0.25
|
|
|
$
|
0.78
|
|
|
$
|
0.75
|
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Accumulated
Deficit
|
|
Total Stockholders' Equity
|
|
Non-Controlling
Interests
|
|
Total
Equity
|
|||||||||||||||
|
Shares
|
|
Amount
|
|||||||||||||||||||||||
Balance at December 31, 2015
|
28,609,650
|
|
|
$
|
284
|
|
|
$
|
421,179
|
|
|
$
|
(11,992
|
)
|
|
$
|
409,471
|
|
|
$
|
47,017
|
|
|
$
|
456,488
|
|
Stock‑based compensation
|
3,022
|
|
|
—
|
|
|
202
|
|
|
—
|
|
|
202
|
|
|
—
|
|
|
202
|
|
||||||
Repurchase and retirement of common stock
|
(129,916
|
)
|
|
(1
|
)
|
|
(1,435
|
)
|
|
—
|
|
|
(1,436
|
)
|
|
—
|
|
|
(1,436
|
)
|
||||||
Net income
|
—
|
|
|
—
|
|
|
—
|
|
|
32,271
|
|
|
32,271
|
|
|
3,876
|
|
|
36,147
|
|
||||||
Dividends declared
|
—
|
|
|
—
|
|
|
—
|
|
|
(22,248
|
)
|
|
(22,248
|
)
|
|
—
|
|
|
(22,248
|
)
|
||||||
Contributions from non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
11
|
|
||||||
Distributions to non-controlling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,896
|
)
|
|
(3,896
|
)
|
||||||
Balance at September 30, 2016
|
28,482,756
|
|
|
$
|
283
|
|
|
$
|
419,946
|
|
|
$
|
(1,969
|
)
|
|
$
|
418,260
|
|
|
$
|
47,008
|
|
|
$
|
465,268
|
|
|
For the nine months ended September 30,
|
||||||
|
2016
|
|
2015
|
||||
|
(unaudited)
|
|
(unaudited)
|
||||
Operating activities:
|
|
|
|
||||
Net income
|
$
|
36,147
|
|
|
$
|
32,268
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities (inclusive of amounts related to discontinued operations):
|
|
|
|
|
|
||
Amortization of deferred financing costs
|
4,782
|
|
|
7,317
|
|
||
Change in mortgage banking activities
|
(10,386
|
)
|
|
(11,200
|
)
|
||
Change in fair value of mortgage servicing rights
|
6,457
|
|
|
6,955
|
|
||
Accretion of deferred loan origination fees and costs
|
(3,717
|
)
|
|
(3,504
|
)
|
||
Provision for loss sharing
|
(146
|
)
|
|
(1,109
|
)
|
||
Cash paid to settle loss sharing obligations
|
(681
|
)
|
|
(2,264
|
)
|
||
Originations of mortgage loans held for sale
|
(639,413
|
)
|
|
(575,038
|
)
|
||
Sale of mortgage loans held for sale to third parties
|
571,714
|
|
|
685,138
|
|
||
Stock-based compensation
|
202
|
|
|
662
|
|
||
Gain on sale of discontinued operations
|
(10,196
|
)
|
|
—
|
|
||
Depreciation expense
|
167
|
|
|
164
|
|
||
Deferred tax expense
|
2,049
|
|
|
1,823
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
Restricted cash
|
1,411
|
|
|
41,916
|
|
||
Other assets
|
39,706
|
|
|
18,918
|
|
||
Due to affiliate
|
284
|
|
|
(46
|
)
|
||
Other liabilities
|
1,805
|
|
|
2,576
|
|
||
Net cash provided by (used in) operating activities
|
185
|
|
|
204,576
|
|
||
Investing activities:
|
|
|
|
|
|
||
Issuance of and fundings on loans held for investment
|
(782,364
|
)
|
|
(153,245
|
)
|
||
Principal repayment of loans held for investment
|
444,272
|
|
|
275,159
|
|
||
Proceeds from sale of a mortgage loan held for sale
|
—
|
|
|
74,625
|
|
||
Receipt of origination fees
|
6,009
|
|
|
810
|
|
||
Proceeds from sale of discontinued operations, net of cash sold
|
89,981
|
|
|
—
|
|
||
Purchases of other assets
|
(354
|
)
|
|
(90
|
)
|
||
Net cash provided by (used in) investing activities
|
(242,456
|
)
|
|
197,259
|
|
||
Financing activities:
|
|
|
|
|
|
||
Proceeds from secured funding agreements
|
1,288,698
|
|
|
170,525
|
|
||
Repayments of secured funding agreements
|
(932,371
|
)
|
|
(201,648
|
)
|
||
Payment of secured funding costs
|
(4,221
|
)
|
|
(1,320
|
)
|
||
Repayments of debt of consolidated VIEs
|
(197,445
|
)
|
|
(243,703
|
)
|
||
Proceeds from warehouse lines of credit
|
863,382
|
|
|
668,055
|
|
||
Repayments of warehouse lines of credit
|
(795,684
|
)
|
|
(777,709
|
)
|
||
Proceeds from secured term loan
|
80,000
|
|
|
—
|
|
||
Repurchase of common stock
|
(1,436
|
)
|
|
—
|
|
||
Dividends paid
|
(21,994
|
)
|
|
(21,446
|
)
|
||
Contributions from non-controlling interests
|
11
|
|
|
5,685
|
|
||
Distributions to non-controlling interests
|
(3,896
|
)
|
|
(6,426
|
)
|
||
Net cash provided by (used in) financing activities
|
275,044
|
|
|
(407,987
|
)
|
||
Change in cash and cash equivalents
|
32,773
|
|
|
(6,152
|
)
|
||
Cash and cash equivalents of continuing operations, beginning of period
|
5,066
|
|
|
15,045
|
|
||
Cash and cash equivalents of discontinued operations, beginning of period
|
3,929
|
|
|
1,506
|
|
||
Cash and cash equivalents, end of period
|
$
|
41,768
|
|
|
$
|
10,399
|
|
Cash and cash equivalents of continuing operations, end of period
|
$
|
41,768
|
|
|
$
|
5,103
|
|
Cash and cash equivalents of discontinued operations, end of period
|
$
|
—
|
|
|
$
|
5,296
|
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Interest income from loans held for investment, excluding non-controlling interests
|
|
$
|
19,473
|
|
|
$
|
18,618
|
|
|
$
|
54,573
|
|
|
$
|
58,251
|
|
Interest income from non-controlling interest investment held by third parties
|
|
1,303
|
|
|
2,331
|
|
|
3,882
|
|
|
6,880
|
|
||||
Interest income from loans held for investment
|
|
$
|
20,776
|
|
|
$
|
20,949
|
|
|
$
|
58,455
|
|
|
$
|
65,131
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Secured funding agreements and securitizations debt
|
$
|
6,914
|
|
|
$
|
7,063
|
|
|
$
|
20,339
|
|
|
$
|
22,737
|
|
Secured term loan
|
2,104
|
|
|
—
|
|
|
5,619
|
|
|
—
|
|
||||
Convertible notes
|
—
|
|
|
1,644
|
|
|
—
|
|
|
4,849
|
|
||||
Interest expense
|
$
|
9,018
|
|
|
$
|
8,707
|
|
|
$
|
25,958
|
|
|
$
|
27,586
|
|
|
As of September 30, 2016
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Interest Rate
|
|
Weighted Average Unleveraged Effective Yield (2)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
1,263,459
|
|
|
$
|
1,271,000
|
|
|
4.7
|
%
|
|
5.4
|
%
|
|
1.9
|
Subordinated debt and preferred equity investments
|
163,882
|
|
|
165,977
|
|
|
10.7
|
%
|
|
11.2
|
%
|
|
4.9
|
||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,427,341
|
|
|
$
|
1,436,977
|
|
|
5.4
|
%
|
|
6.1
|
%
|
|
2.2
|
|
As of December 31, 2015
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Interest Rate
|
|
Weighted Average Unleveraged Effective Yield (2)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
961,395
|
|
|
$
|
965,578
|
|
|
4.4
|
%
|
|
5.1
|
%
|
|
1.4
|
Subordinated debt and preferred equity investments
|
166,417
|
|
|
168,264
|
|
|
10.6
|
%
|
|
11.2
|
%
|
|
5.1
|
||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,127,812
|
|
|
$
|
1,133,842
|
|
|
5.3
|
%
|
|
6.0
|
%
|
|
1.9
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal face amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs. The tables above exclude non-controlling interests held by third parties. A reconciliation of the Carrying Amount of loans held for investment portfolio, excluding non-controlling interests, to the Carrying Amount of loans held for investment, as included within the Company's consolidated balance sheets, is presented below.
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes no dispositions, early prepayments or defaults. The Total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of
September 30, 2016 and December 31, 2015
as weighted by the Outstanding Principal balance of each loan.
|
|
As of September 30, 2016
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,427,341
|
|
|
$
|
1,436,977
|
|
Non-controlling interest investment held by third parties
|
46,579
|
|
|
46,579
|
|
||
Loans held for investment
|
$
|
1,473,920
|
|
|
$
|
1,483,556
|
|
|
As of December 31, 2015
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,127,812
|
|
|
$
|
1,133,842
|
|
Non-controlling interest investment held by third parties
|
46,579
|
|
|
46,579
|
|
||
Loans held for investment
|
$
|
1,174,391
|
|
|
$
|
1,180,421
|
|
Loan Type
|
|
Location
|
|
Outstanding Principal (1)
|
|
Carrying Amount (1)
|
|
Interest Rate
|
|
Unleveraged Effective Yield (2)
|
|
Maturity Date (3)
|
|
Payment Terms (4)
|
|
Senior Mortgage Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Various
|
(5)
|
Diversified
|
|
$159.2
|
|
$157.7
|
|
L+4.35%
|
|
5.6%
|
|
Oct 2018
|
|
I/O
|
|
Various
|
(6)
|
Diversified
|
|
98.9
|
|
97.9
|
|
L+4.75%
|
|
6.0%
|
|
Oct 2018
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
89.7
|
|
89.2
|
|
L+4.75%
|
|
5.8%
|
|
Sep 2019
|
|
I/O
|
|
Office
|
|
TX
|
|
84.4
|
|
84.3
|
|
L+5.00%
|
|
6.3%
|
|
Jan 2017
|
|
I/O
|
|
Retail
|
|
IL
|
|
75.9
|
|
75.7
|
|
L+4.00%
|
|
4.9%
|
|
Aug 2017
|
|
I/O
|
|
Mixed-use
|
|
NY
|
|
65.6
|
|
65.2
|
|
L+4.16%
|
|
5.1%
|
|
Apr 2019
|
|
I/O
|
|
Office
|
|
CA
|
|
57.5
|
|
56.9
|
|
L+4.40%
|
|
5.5%
|
|
Aug 2019
|
|
I/O
|
|
Hotel
|
|
CA
|
|
56.0
|
|
55.6
|
|
L+4.75%
|
|
6.0%
|
|
Feb 2019
|
|
I/O
|
|
Office
|
|
IL
|
|
53.2
|
|
52.5
|
|
L+3.99%
|
|
5.0%
|
|
Aug 2019
|
|
I/O
|
|
Multifamily
|
|
FL
|
|
45.4
|
|
45.1
|
|
L+4.75%
|
|
5.8%
|
|
Sep 2019
|
|
I/O
|
|
Healthcare
|
|
NY
|
|
41.6
|
|
41.6
|
|
L+5.00%
|
|
6.0%
|
|
Dec 2016
|
|
I/O
|
|
Office
|
|
FL
|
|
36.7
|
|
36.7
|
|
L+3.65%
|
|
4.3%
|
|
Oct 2017
|
|
I/O
|
|
Hotel
|
|
NY
|
|
36.5
|
|
36.3
|
|
L+4.75%
|
|
5.7%
|
|
June 2018
|
|
I/O
|
|
Hotel
|
|
MI
|
|
35.2
|
|
35.2
|
|
L+4.15%
|
|
4.9%
|
|
July 2017
|
|
I/O
|
|
Multifamily
|
|
MN
|
|
34.1
|
|
33.8
|
|
L+4.75%
|
|
5.8%
|
|
Oct 2019
|
|
I/O
|
|
Industrial
|
|
OH
|
|
32.5
|
|
32.4
|
|
L+4.20%
|
|
5.0%
|
|
May 2018
|
|
I/O
|
(7)
|
Retail
|
|
IL
|
|
30.4
|
|
30.2
|
|
L+3.25%
|
|
4.2%
|
|
Sep 2018
|
|
I/O
|
|
Office
|
|
OR
|
|
29.4
|
|
29.2
|
|
L+3.75%
|
|
4.7%
|
|
Oct 2018
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
29.2
|
|
29.1
|
|
L+3.75%
|
|
4.7%
|
|
Oct 2017
|
|
I/O
|
|
Mixed-use
|
|
NY
|
|
28.4
|
|
28.4
|
|
L+4.25%
|
|
5.1%
|
|
Aug 2017
|
|
I/O
|
|
Multifamily
|
|
TX
|
|
24.9
|
|
24.8
|
|
L+3.80%
|
|
4.5%
|
|
Jan 2019
|
|
I/O
|
|
Multifamily
|
|
AZ
|
|
22.1
|
|
22.0
|
|
L+4.25%
|
|
5.5%
|
|
Sep 2017
|
(8)
|
I/O
|
|
Multifamily
|
|
FL
|
|
19.8
|
|
19.5
|
|
L+4.25%
|
|
5.5%
|
|
Feb 2019
|
|
I/O
|
|
Office
|
|
PA
|
|
19.6
|
|
19.4
|
|
L+4.70%
|
|
5.7%
|
|
Mar 2020
|
|
I/O
|
|
Office
|
|
CO
|
|
19.5
|
|
19.4
|
|
L+3.95%
|
|
4.9%
|
|
Dec 2017
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
15.3
|
|
15.3
|
|
L+3.85%
|
|
4.7%
|
|
Nov 2017
|
|
I/O
|
|
Mixed-use
|
|
NY
|
|
15.1
|
|
15.0
|
|
L+3.95%
|
|
5.1%
|
|
Sep 2017
|
|
I/O
|
|
Office
|
|
CA
|
|
14.9
|
|
15.0
|
|
L+4.50%
|
|
5.0%
|
|
July 2018
|
|
I/O
|
|
Subordinated Debt and Preferred Equity Investments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Various
|
(9)
|
Diversified
|
|
48.5
|
|
47.5
|
|
10.95%
|
|
11.7%
|
|
Dec 2024
|
|
I/O
|
|
Multifamily
|
|
GA/FL
|
|
36.0
|
|
35.7
|
|
L+11.85%
|
(10)
|
12.6%
|
|
June 2021
|
|
I/O
|
|
Multifamily
|
|
NY
|
|
33.3
|
|
33.2
|
|
L+8.07%
|
|
8.9%
|
|
Jan 2019
|
|
I/O
|
|
Office
|
|
NJ
|
|
17.0
|
|
16.3
|
|
12.00%
|
|
12.8%
|
|
Jan 2026
|
|
I/O
|
(7)
|
Mixed-use
|
|
NY
|
|
16.9
|
|
16.9
|
|
11.50%
|
(11)
|
12.1%
|
|
Nov 2016
|
|
I/O
|
|
Office
|
|
GA
|
|
14.3
|
|
14.3
|
|
9.50%
|
|
9.5%
|
|
Aug 2017
|
|
I/O
|
|
Total/Weighted Average
|
|
|
|
$1,437.0
|
|
$1,427.3
|
|
|
|
6.1%
|
|
|
|
|
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes no dispositions, early prepayments or defaults. Unleveraged Effective Yield for each loan is calculated based on LIBOR as of
September 30, 2016
or the LIBOR floor, as applicable. The Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by the Company as of
September 30, 2016
as weighted by the Outstanding Principal balance of each loan.
|
(3)
|
Certain loans are subject to contractual extension options that vary between
one
and
two
12-month extensions and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities in connection with loan modifications.
|
(4)
|
I/O = interest only, P/I = principal and interest.
|
(5)
|
The senior mortgage loan, which had an outstanding principal balance of
$159.2 million
as of
September 30, 2016
, is collateralized by a portfolio of assets comprised of self-storage, retail and office properties.
|
(6)
|
The senior mortgage loan, which had an outstanding principal balance of $
98.9 million
as of
September 30, 2016
, is collateralized by a portfolio of assets comprised of self-storage and retail properties.
|
(7)
|
In May 2017, amortization will begin on the senior Ohio loan, which had an outstanding principal balance of $
32.5
million as of
September 30, 2016
. In February 2021, amortization will begin on the subordinated New Jersey loan,
|
(8)
|
In June 2016, the Company extended the maturity date on the senior Arizona loan to September 2017 in accordance with the loan agreement.
|
(9)
|
The preferred equity investment is in an entity whose assets are comprised of multifamily, student housing and medical office properties.
|
(10)
|
The preferred return is L+
11.85%
with
2.00%
as payment-in-kind ("PIK"), to the extent cash flow is not available. There is no capped dollar amount on accrued PIK.
|
(11)
|
The interest rate is
11.50%
with a
9.00%
current pay and up to a capped dollar amount as PIK based on the borrower’s election. In July 2015, the Company entered into an amendment to increase the loan commitment and outstanding principal by $
650 thousand
at an interest rate of
15.00%
on the increased commitment and outstanding principal only.
|
Balance at December 31, 2015
|
$
|
1,174,391
|
|
Initial funding
|
756,392
|
|
|
Origination fees and discounts, net of costs
|
(7,323
|
)
|
|
Additional funding
|
27,951
|
|
|
Amortizing payments
|
(463
|
)
|
|
Loan payoffs
|
(480,745
|
)
|
|
Origination fee accretion
|
3,717
|
|
|
Balance at September 30, 2016
|
$
|
1,473,920
|
|
|
|
|
|
|
|
|||||||||||
|
September 30, 2016
|
|
December 31, 2015
|
|
||||||||||||
|
Outstanding Balance
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Total
Commitment |
|
||||||||
Wells Fargo Facility
|
$
|
229,255
|
|
|
$
|
325,000
|
|
|
$
|
101,473
|
|
|
$
|
225,000
|
|
|
Citibank Facility
|
319,925
|
|
|
250,000
|
|
(1)
|
112,827
|
|
|
250,000
|
|
|
||||
BAML Facility
|
77,679
|
|
|
125,000
|
|
(2)
|
—
|
|
|
50,000
|
|
|
||||
March 2014 CNB Facility
|
—
|
|
|
50,000
|
|
|
—
|
|
|
50,000
|
|
|
||||
July 2014 CNB Facility
|
—
|
|
(3)
|
—
|
|
(3)
|
66,200
|
|
|
75,000
|
|
|
||||
MetLife Facility
|
111,999
|
|
|
180,000
|
|
|
109,474
|
|
|
180,000
|
|
|
||||
April 2014 UBS Facility
|
82,004
|
|
|
140,000
|
|
|
75,558
|
|
|
140,000
|
|
|
||||
December 2014 UBS Facility
|
—
|
|
(4)
|
—
|
|
(4)
|
57,243
|
|
|
57,243
|
|
|
||||
U.S. Bank Facility
|
58,240
|
|
|
125,000
|
|
(5)
|
—
|
|
|
—
|
|
|
||||
Secured Term Loan
|
155,000
|
|
|
155,000
|
|
|
75,000
|
|
|
155,000
|
|
|
||||
Total
|
$
|
1,034,102
|
|
|
$
|
1,350,000
|
|
|
$
|
597,775
|
|
|
$
|
1,182,243
|
|
|
(1)
|
In July 2016, the Company entered into an amendment to the CitiBank Facility (defined below), which added an accordion feature that provides for an increase in the
$250.0 million
commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion.
|
(2)
|
In August 2016, the Company amended and restated the existing BAML Facility (defined below) to increase its commitment size from
$50.0 million
to
$125.0 million
.
|
(3)
|
The July 2014 CNB Facility (defined below) has been repaid in full and its terms were not extended.
|
(4)
|
The December 2014 UBS Facility (defined below) has been repaid in full and its terms were not extended.
|
(5)
|
In August 2016, the Company entered into a $
125.0
million master repurchase and securities contract with U.S. Bank (defined below).
|
|
As of
|
||||||
|
September 30, 2016
|
|
December 31, 2015
|
||||
Total commitments
|
$
|
1,531,568
|
|
|
$
|
1,232,163
|
|
Less: funded commitments
|
(1,436,977
|
)
|
|
(1,133,842
|
)
|
||
Total unfunded commitments
|
$
|
94,591
|
|
|
$
|
98,321
|
|
Grant Date
|
|
Vesting Start Date
|
|
Shares Granted
|
May 1, 2012
|
|
July 1, 2012
|
|
35,135
|
June 18, 2012
|
|
July 1, 2012
|
|
7,027
|
July 9, 2012
|
|
October 1, 2012
|
|
25,000
|
June 26, 2013
|
|
July 1, 2013
|
|
22,526
|
November 25, 2013
|
|
November 25, 2016
|
|
30,381
|
January 31, 2014
|
|
August 31, 2015
|
|
48,273
|
February 26, 2014
|
|
February 26, 2014
|
|
12,030
|
February 27, 2014
|
|
August 27, 2014
|
|
22,354
|
June 24, 2014
|
|
June 24, 2014
|
|
17,658
|
June 24, 2015
|
|
July 1, 2015
|
|
25,555
|
April 25, 2016
|
|
July 1, 2016
|
|
10,000
|
June 27, 2016
|
|
July 1, 2016
|
|
24,680
|
Total
|
|
|
|
280,619
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officer
|
|
Restricted Stock Grants—Employees
|
|
Total
|
||||
Balance at December 31, 2015
|
16,945
|
|
|
4,686
|
|
|
62,563
|
|
|
84,194
|
|
Granted
|
34,680
|
|
|
—
|
|
|
—
|
|
|
34,680
|
|
Vested
|
(20,996
|
)
|
|
(4,686
|
)
|
|
(32,182
|
)
|
|
(57,864
|
)
|
Forfeited
|
(1,277
|
)
|
|
—
|
|
|
(30,381
|
)
|
|
(31,658
|
)
|
Balance at September 30, 2016
|
29,352
|
|
|
—
|
|
|
—
|
|
|
29,352
|
|
|
Restricted Stock Grants—Directors
|
|
Restricted Stock Grants—Officer
|
|
Restricted Stock Grants—Employees
|
|
Total
|
||||
2016
|
7,838
|
|
|
—
|
|
|
—
|
|
|
7,838
|
|
2017
|
16,510
|
|
|
—
|
|
|
—
|
|
|
16,510
|
|
2018
|
3,336
|
|
|
—
|
|
|
—
|
|
|
3,336
|
|
2019
|
1,668
|
|
|
—
|
|
|
—
|
|
|
1,668
|
|
2020
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Total
|
29,352
|
|
|
—
|
|
|
—
|
|
|
29,352
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Net income from continuing operations, less non-controlling interests
|
$
|
6,380
|
|
|
$
|
6,402
|
|
|
$
|
17,854
|
|
|
$
|
20,390
|
|
Net income from discontinued operations, including gain on sale of discontinued operations
|
$
|
12,062
|
|
|
$
|
2,977
|
|
|
$
|
14,417
|
|
|
$
|
5,018
|
|
Divided by:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic weighted average shares of common stock outstanding:
|
28,428,766
|
|
|
28,505,729
|
|
|
28,462,143
|
|
|
28,493,989
|
|
||||
Non-vested restricted stock
|
84,371
|
|
|
103,921
|
|
|
74,778
|
|
|
99,507
|
|
||||
Diluted weighted average shares of common stock outstanding:
|
28,513,137
|
|
|
28,609,650
|
|
|
28,536,921
|
|
|
28,593,496
|
|
||||
Basic earnings per common share (1):
|
|
|
|
|
|
|
|
|
|
|
|
||||
Continuing operations
|
$
|
0.22
|
|
|
$
|
0.22
|
|
|
$
|
0.63
|
|
|
$
|
0.72
|
|
Discontinued operations
|
0.42
|
|
|
0.10
|
|
|
0.51
|
|
|
0.18
|
|
||||
Net income
|
$
|
0.65
|
|
|
$
|
0.33
|
|
|
$
|
1.13
|
|
|
$
|
0.89
|
|
Diluted earnings per common share (1):
|
|
|
|
|
|
|
|
|
|
|
|
||||
Continuing operations
|
$
|
0.22
|
|
|
$
|
0.22
|
|
|
$
|
0.63
|
|
|
$
|
0.71
|
|
Discontinued operations
|
0.42
|
|
|
0.10
|
|
|
0.51
|
|
|
0.18
|
|
||||
Net income
|
$
|
0.65
|
|
|
$
|
0.33
|
|
|
$
|
1.13
|
|
|
$
|
0.89
|
|
(1)
|
The Company has considered the impact of the 2015 Convertible Notes and the restricted shares on diluted earnings per common share. The number of shares of common stock that the 2015 Convertible Notes are convertible into were not included in the computation of diluted net income per common share because the inclusion of those shares would have been anti-dilutive for the three and nine months ended September 30, 2015.
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Current
|
$
|
4
|
|
|
$
|
3
|
|
|
$
|
11
|
|
|
$
|
(15
|
)
|
Deferred
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Excise tax
|
157
|
|
|
—
|
|
|
157
|
|
|
—
|
|
||||
Total income tax expense (benefit), including
excise tax
|
$
|
161
|
|
|
$
|
3
|
|
|
$
|
168
|
|
|
$
|
(15
|
)
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||
Federal statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
State income taxes
|
4.4
|
%
|
|
3.6
|
%
|
|
4.4
|
%
|
|
3.6
|
%
|
Federal benefit of state tax deduction
|
(1.5
|
)%
|
|
(1.3
|
)%
|
|
(1.5
|
)%
|
|
(1.3
|
)%
|
Effective tax rate
|
37.9
|
%
|
|
37.3
|
%
|
|
37.9
|
%
|
|
37.3
|
%
|
•
|
Level II-Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants would use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk and others.
|
•
|
Level III-Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used.
|
|
|
|
As of
|
||||||||||||||
|
|
|
September 30, 2016
|
|
December 31, 2015
|
||||||||||||
|
Level in Fair Value Hierarchy
|
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
||||||||
Financial assets:
|
|
|
|
|
|
|
|
|
|
||||||||
Loans held for investment
|
3
|
|
$
|
1,473,920
|
|
|
$
|
1,483,556
|
|
|
$
|
1,174,391
|
|
|
$
|
1,180,421
|
|
Financial liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Secured funding agreements
|
2
|
|
$
|
879,102
|
|
|
$
|
879,102
|
|
|
$
|
522,775
|
|
|
$
|
522,775
|
|
Secured term loan
|
2
|
|
149,270
|
|
|
155,000
|
|
|
69,762
|
|
|
75,000
|
|
||||
Commercial mortgage-backed securitization debt (consolidated VIE)
|
3
|
|
—
|
|
|
—
|
|
|
61,815
|
|
|
61,856
|
|
||||
Collateralized loan obligation securitization debt (consolidated VIE)
|
3
|
|
57,787
|
|
|
57,830
|
|
|
192,528
|
|
|
193,419
|
|
|
Incurred
|
|
Payable
|
||||||||||||||||||||
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
|
As of
|
||||||||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
September 30, 2016
|
|
December 31, 2015
|
||||||||||||
Affiliate Payments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Management fees
|
$
|
1,369
|
|
|
$
|
1,351
|
|
|
$
|
4,059
|
|
|
$
|
4,040
|
|
|
$
|
1,369
|
|
|
$
|
1,357
|
|
Incentive fees
|
321
|
|
|
—
|
|
|
321
|
|
|
—
|
|
|
321
|
|
|
—
|
|
||||||
General and administrative expenses
|
860
|
|
|
840
|
|
|
2,417
|
|
|
2,591
|
|
|
860
|
|
|
835
|
|
||||||
Direct costs
|
227
|
|
|
353
|
|
|
730
|
|
|
1,138
|
|
|
53
|
|
|
232
|
|
||||||
Total
|
$
|
2,777
|
|
|
$
|
2,544
|
|
|
$
|
7,527
|
|
|
$
|
7,769
|
|
|
$
|
2,603
|
|
|
$
|
2,424
|
|
Date declared
|
|
Record date
|
|
Payment date
|
|
Per share amount
|
|
Total amount
|
||||
August 4, 2016
|
|
September 30, 2016
|
|
October 17, 2016
|
|
$
|
0.26
|
|
|
$
|
7,406
|
|
May 5, 2016
|
|
June 30, 2016
|
|
July 15, 2016
|
|
0.26
|
|
|
7,413
|
|
||
March 1, 2016
|
|
March 31, 2016
|
|
April 15, 2016
|
|
0.26
|
|
|
7,429
|
|
||
Total cash dividends declared for the nine months ended September 30, 2016
|
|
|
|
|
|
$
|
0.78
|
|
|
$
|
22,248
|
|
|
|
|
|
|
|
|
|
|
||||
July 30, 2015
|
|
September 30, 2015
|
|
October 15, 2015
|
|
$
|
0.25
|
|
|
$
|
7,152
|
|
May 7, 2015
|
|
June 30, 2015
|
|
July 15, 2015
|
|
0.25
|
|
|
7,152
|
|
||
March 5, 2015
|
|
March 31, 2015
|
|
April 15, 2015
|
|
0.25
|
|
|
7,146
|
|
||
Total cash dividends declared for the nine months ended September 30, 2015
|
|
|
|
|
|
$
|
0.75
|
|
|
$
|
21,450
|
|
|
As of
|
||||||
|
September 30, 2016
|
|
December 31, 2015
|
||||
Carrying value
|
$
|
35,722
|
|
|
$
|
55,144
|
|
Maximum exposure to loss
|
$
|
36,040
|
|
|
$
|
55,704
|
|
|
As of
|
||||||
|
September 30, 2016
|
|
December 31, 2015
|
||||
ASSETS
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
—
|
|
|
$
|
3,929
|
|
Restricted cash
|
—
|
|
|
17,297
|
|
||
Loans held for sale, at fair value
|
—
|
|
|
30,612
|
|
||
Mortgage servicing rights, at fair value
|
—
|
|
|
61,800
|
|
||
Other assets
|
—
|
|
|
19,613
|
|
||
Assets of discontinued operations
|
$
|
—
|
|
|
$
|
133,251
|
|
LIABILITIES
|
|
|
|
|
|
||
Warehouse lines of credit
|
$
|
—
|
|
|
$
|
24,806
|
|
Allowance for loss sharing
|
—
|
|
|
8,969
|
|
||
Due to affiliate
|
—
|
|
|
234
|
|
||
Other liabilities
|
—
|
|
|
17,522
|
|
||
Liabilities of discontinued operations
|
$
|
—
|
|
|
$
|
51,531
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Mortgage banking revenue:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Servicing fees, net
|
$
|
4,115
|
|
|
$
|
4,114
|
|
|
$
|
11,081
|
|
|
$
|
11,938
|
|
Gains from mortgage banking activities
|
10,862
|
|
|
9,214
|
|
|
24,034
|
|
|
20,847
|
|
||||
Provision for loss sharing
|
(143
|
)
|
|
118
|
|
|
146
|
|
|
1,109
|
|
||||
Change in fair value of mortgage servicing rights
|
(2,562
|
)
|
|
(1,772
|
)
|
|
(6,457
|
)
|
|
(6,955
|
)
|
||||
Mortgage banking revenue
|
12,272
|
|
|
11,674
|
|
|
28,804
|
|
|
26,939
|
|
||||
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Management fees to affiliate
|
154
|
|
|
139
|
|
|
446
|
|
|
407
|
|
||||
Professional fees
|
347
|
|
|
280
|
|
|
718
|
|
|
757
|
|
||||
Compensation and benefits
|
7,864
|
|
|
5,921
|
|
|
18,108
|
|
|
15,992
|
|
||||
Transaction costs
|
282
|
|
|
—
|
|
|
797
|
|
|
—
|
|
||||
General and administrative expenses
|
1,011
|
|
|
1,016
|
|
|
3,049
|
|
|
3,033
|
|
||||
General and administrative expenses reimbursed to affiliate
|
185
|
|
|
113
|
|
|
622
|
|
|
368
|
|
||||
Total expenses
|
9,843
|
|
|
7,469
|
|
|
23,740
|
|
|
20,557
|
|
||||
Income from operations before income taxes
|
2,429
|
|
|
4,205
|
|
|
5,064
|
|
|
6,382
|
|
||||
Income tax expense
|
563
|
|
|
1,228
|
|
|
843
|
|
|
1,364
|
|
||||
Net income from operations of discontinued operations, net of income taxes
|
$
|
1,866
|
|
|
$
|
2,977
|
|
|
$
|
4,221
|
|
|
$
|
5,018
|
|
Balance at December 31, 2015 (1)
|
$
|
61,800
|
|
MSRs purchased
|
323
|
|
|
Additions, following sale of loan
|
10,275
|
|
|
Changes in fair value
|
(6,457
|
)
|
|
Prepayments and write-offs
|
(3,058
|
)
|
|
MSRs included in the ACRE Capital Sale
|
(62,883
|
)
|
|
Balance at September 30, 2016
|
$
|
—
|
|
Balance at December 31, 2014
|
$
|
58,889
|
|
Additions, following sale of loan
|
10,050
|
|
|
Changes in fair value
|
(6,955
|
)
|
|
Prepayments and write-offs
|
(1,836
|
)
|
|
Balance at September 30, 2015
|
$
|
60,148
|
|
(1)
|
MSRs are included in mortgage servicing rights at fair value as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities of discontinued operations that are presented separately in the consolidated balance sheets.
|
Balance at December 31, 2015 (1)
|
$
|
8,969
|
|
Current period provision for loss sharing
|
(146
|
)
|
|
Settlements/Writeoffs
|
(788
|
)
|
|
Allowance for loss sharing included in the ACRE Capital Sale
|
(8,035
|
)
|
|
Balance at September 30, 2016
|
$
|
—
|
|
Balance at December 31, 2014
|
$
|
12,349
|
|
Current period provision for loss sharing
|
(1,109
|
)
|
|
Settlements/Writeoffs
|
(2,287
|
)
|
|
Balance at September 30, 2015
|
$
|
8,953
|
|
(1)
|
Allowance for loss sharing was included in allowance for loss sharing as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities of discontinued operations that are presented separately in the Company's consolidated balance sheets.
|
|
|
As of December 31, 2015
|
||
Commitments to sell loans
|
|
$
|
237,372
|
|
Commitments to fund loans
|
|
$
|
207,566
|
|
|
|
As of December 31, 2015
|
||||
Derivatives not designated as hedging instruments
|
|
Balance Sheet Location
|
|
Fair Value
|
||
Loan commitments
|
|
Assets of discontinued operations
|
(1)
|
$
|
8,450
|
|
Forward sale commitments
|
|
Assets of discontinued operations
|
(1)
|
25
|
|
|
MSR purchase commitment
|
|
Assets of discontinued operations
|
(1)
|
330
|
|
|
Forward sale commitments
|
|
Liabilities of discontinued operations
|
(1)
|
(1,868
|
)
|
|
Total derivatives not designated as hedging instruments
|
|
|
|
$
|
6,937
|
|
(1)
|
Derivative financial instruments are included in other assets or other liabilities as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Current
|
$
|
(804
|
)
|
|
$
|
73
|
|
|
$
|
(1,206
|
)
|
|
$
|
(459
|
)
|
Deferred
|
1,367
|
|
|
1,155
|
|
|
2,049
|
|
|
1,823
|
|
||||
Total income tax expense
|
$
|
563
|
|
|
$
|
1,228
|
|
|
$
|
843
|
|
|
$
|
1,364
|
|
|
As of December 31, 2015
|
||
Deferred tax assets
|
|
||
Mortgage servicing rights
|
$
|
4,083
|
|
Net operating loss carryforward
|
2,906
|
|
|
Other temporary differences
|
1,762
|
|
|
Sub-total-deferred tax assets
|
8,751
|
|
|
Deferred tax liabilities
|
|
|
|
Basis difference in assets from acquisition of ACRE Capital
|
(2,709
|
)
|
|
Components of gains from mortgage banking activities
|
(9,344
|
)
|
|
Amortization of intangible assets
|
(297
|
)
|
|
Sub-total-deferred tax liabilities
|
(12,350
|
)
|
|
Net deferred tax liability
|
$
|
(3,599
|
)
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||
Federal statutory rate
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
|
35.0
|
%
|
State income taxes
|
4.4
|
%
|
|
3.6
|
%
|
|
4.4
|
%
|
|
3.6
|
%
|
Federal benefit of state tax deduction
|
(1.5
|
)%
|
|
(1.3
|
)%
|
|
(1.5
|
)%
|
|
(1.3
|
)%
|
Effective tax rate
|
37.9
|
%
|
|
37.3
|
%
|
|
37.9
|
%
|
|
37.3
|
%
|
|
Fair Value as of December 31, 2015
|
||||||||||||||
|
Level I
|
|
Level II
|
|
Level III
|
|
Total
|
||||||||
Loans held for sale
|
$
|
—
|
|
|
$
|
30,612
|
|
|
$
|
—
|
|
|
$
|
30,612
|
|
Mortgage servicing rights
|
—
|
|
|
—
|
|
|
61,800
|
|
|
61,800
|
|
||||
Derivative assets:
|
|
|
|
|
|
|
|
|
|||||||
Loan commitments
|
—
|
|
|
—
|
|
|
8,450
|
|
|
8,450
|
|
||||
Forward sale commitments
|
—
|
|
|
—
|
|
|
25
|
|
|
25
|
|
||||
MSR purchase commitment
|
—
|
|
|
—
|
|
|
330
|
|
|
330
|
|
||||
Derivative liabilities:
|
|
|
|
|
|
|
|
||||||||
Forward sale commitments
|
—
|
|
|
—
|
|
|
(1,868
|
)
|
|
(1,868
|
)
|
|
|
|
|
|
|
Unobservable Input
|
||||||
|
|
Fair
|
|
Primary
|
|
|
|
|
|
Weighted
|
||
Asset Category
|
|
Value
|
|
Valuation Technique
|
|
Input
|
|
Range
|
|
Average
|
||
Mortgage servicing rights
|
|
$
|
61,800
|
|
|
Discounted cash flow
|
|
Discount rate
|
|
8 - 14%
|
|
11.1%
|
Loan commitments and forward sale commitments
|
|
$
|
6,607
|
|
|
Discounted cash flow
|
|
Discount rate
|
|
8 - 12%
|
|
8.2%
|
MSR purchase commitment
|
|
$
|
330
|
|
|
Discounted cash flow
|
|
Discount rate
|
|
8%
|
|
8.0%
|
Balance at December 31, 2015
|
$
|
6,937
|
|
Settlements
|
(35,680
|
)
|
|
Realized gains (losses) recorded in net income (1)
|
28,743
|
|
|
Unrealized gains (losses) recorded in net income (1)
|
6,618
|
|
|
Derivative assets and liabilities included in the ACRE Capital Sale
|
(6,618
|
)
|
|
Balance at September 30, 2016
|
$
|
—
|
|
Balance at December 31, 2014
|
$
|
1,670
|
|
Settlements
|
(22,537
|
)
|
|
Realized gains (losses) recorded in net income (1)
|
20,867
|
|
|
Unrealized gains (losses) recorded in net income (1)
|
4,364
|
|
|
Balance at September 30, 2015
|
$
|
4,364
|
|
(1)
|
Realized and unrealized gains (losses) are included in gains from mortgage banking activities for the
three and nine months ended September 30, 2016 and 2015
in the reconciliation of net income from operations of discontinued operations, net of income taxes. See above for more information.
|
|
Incurred
|
|
Payable
|
||||||||||||||||
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
|
As of
|
||||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
|
December 31, 2015
|
||||||||||
Affiliate Payments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Management fees (1)
|
$
|
154
|
|
|
$
|
139
|
|
|
$
|
446
|
|
|
$
|
407
|
|
|
$
|
144
|
|
General and administrative expenses (1)
|
185
|
|
|
113
|
|
|
622
|
|
|
368
|
|
|
84
|
|
|||||
Direct costs (1)
|
35
|
|
|
4
|
|
|
68
|
|
|
20
|
|
|
6
|
|
|||||
Total
|
$
|
374
|
|
|
$
|
256
|
|
|
$
|
1,136
|
|
|
$
|
795
|
|
|
$
|
234
|
|
(1)
|
Related party costs payable are included in due to affiliate as of
December 31, 2015
in the reconciliation of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities of discontinued operations that are presented separately in the Company's consolidated balance sheets. Management fees incurred are included in management fees to affiliate, general and administrative expenses incurred are included in general and administrative expenses reimbursed to affiliate and direct costs incurred are included in general and administrative expenses for the
three and nine months ended September 30, 2016 and 2015
in the reconciliation of net income from operations of discontinued operations, net of income taxes.
|
•
|
our business and investment strategy;
|
•
|
our projected operating results;
|
•
|
the return or impact of current and future investments;
|
•
|
the timing of cash flows, if any, from our investments;
|
•
|
estimates relating to our ability to make distributions to our stockholders in the future;
|
•
|
defaults by borrowers in paying debt service on outstanding indebtedness;
|
•
|
our ability to obtain and maintain financing arrangements, including securitizations;
|
•
|
market conditions and our ability to access alternative debt markets and additional debt and equity capital;
|
•
|
the amount of commercial mortgage loans requiring refinancing;
|
•
|
our expected investment capacity and available capital;
|
•
|
financing and advance rates for our target investments;
|
•
|
our expected leverage;
|
•
|
changes in interest rates and the market value of our investments;
|
•
|
effects of hedging instruments on our target investments;
|
•
|
rates of default or decreased recovery rates on our target investments;
|
•
|
rates of prepayments on our mortgage loans and the effect on our business of such prepayments;
|
•
|
the degree to which our hedging strategies may or may not protect us from interest rate volatility;
|
•
|
availability of investment opportunities in mortgage-related and real estate-related investments and securities;
|
•
|
the ability of Ares Commercial Real Estate Management LLC ("ACREM" or our "Manager") to locate suitable investments for us, monitor, service and administer our investments and execute our investment strategy;
|
•
|
allocation of investment opportunities to us by our Manager;
|
•
|
our ability to successfully complete and integrate any acquisitions;
|
•
|
our ability to maintain our qualification as a real estate investment trust ("REIT") for U.S. federal income tax purposes;
|
•
|
our ability to maintain our exemption from registration under the Investment Company Act of 1940 (the "1940 Act");
|
•
|
our understanding of our competition;
|
•
|
general volatility of the securities markets in which we may invest;
|
•
|
adverse changes in the real estate, real estate capital and credit markets and the impact of a protracted decline in the liquidity of credit markets on our business;
|
•
|
changes in governmental regulations, tax law and rates, and similar matters (including interpretation thereof);
|
•
|
actions and initiatives of the U.S. Government and changes to U.S. Government policies;
|
•
|
the state of the U.S. economy generally or in specific geographic regions;
|
•
|
uncertainty surrounding the financial stability of the United States, European Union and China;
|
•
|
global economic trends and economic recoveries;
|
•
|
market trends in our industry, interest rates, real estate values, the debt securities markets or the general economy; and
|
•
|
our ability to redeploy the net proceeds from the sale of ACRE Capital Holdings LLC ("TRS Holdings"), the holding company that owned our mortgage banking subsidiary, ACRE Capital LLC ("ACRE Capital").
|
•
|
ACRE originated a $159.2 million senior mortgage loan collateralized by a portfolio of assets comprised of self-storage, retail and office properties across a multi-state area.
|
•
|
ACRE originated a $99.0 million senior mortgage loan collateralized by a portfolio of assets comprised of self-storage and retail properties across a multi-state area.
|
•
|
ACRE originated a $89.7 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE originated a $62.5 million senior mortgage loan on an office property located in California.
|
•
|
ACRE originated a $45.4 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE originated a $34.1 million senior mortgage loan on a multifamily property located in Minnesota.
|
•
|
ACRE originated a $23.3 million senior mortgage loan on a multifamily property located in Florida.
|
•
|
ACRE originated a $20.1 million senior mortgage loan on an office property located in Pennsylvania.
|
•
|
ACRE amended its
$250.0
million master repurchase facility (the “Citibank Facility”) with Citibank, N.A., which added an accordion feature that provides for an increase in the $250.0 million commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion.
|
•
|
ACRE amended and restated the existing $50.0 million Bridge Loan Warehousing Credit and Security Agreement with Bank of America, N.A. (the “BAML Facility”) to increase its commitment size from $50.0 million to $125.0 million.
|
•
|
ACRE repaid in full its $75.0 million revolving funding facility (the “July 2014 CNB Facility”) and its terms were not extended.
|
•
|
ACRE entered into a $125.0 million master repurchase and securities contract (the "U.S. Bank Facility") with U.S. Bank National Association ("U.S. Bank").
|
•
|
ACRE drew the remaining $80.0 million commitment under the Credit and Guaranty Agreement (the ‘‘Secured Term Loan”) with Highbridge Principal Strategies, LLC, as administrative agent, and DBD Credit Funding LLC, as collateral agent.
|
•
|
ACRE closed the ACRE Capital Sale.
|
|
As of September 30, 2016
|
||||||||||||||
|
Carrying Amount (1)
|
|
Outstanding Principal (1)
|
|
Weighted Average Interest Rate
|
|
Weighted Average Unleveraged Effective Yield (2)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Senior mortgage loans
|
$
|
1,263,459
|
|
|
$
|
1,271,000
|
|
|
4.7
|
%
|
|
5.4
|
%
|
|
1.9
|
Subordinated debt and preferred equity investments
|
163,882
|
|
|
165,977
|
|
|
10.7
|
%
|
|
11.2
|
%
|
|
4.9
|
||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,427,341
|
|
|
$
|
1,436,977
|
|
|
5.4
|
%
|
|
6.1
|
%
|
|
2.2
|
(1)
|
The difference between the Carrying Amount and the Outstanding Principal face amount of the loans held for investment consists of unamortized purchase discount, deferred loan fees and loan origination costs.
|
(2)
|
Unleveraged Effective Yield is the compounded effective rate of return that would be earned over the life of the investment based on the contractual interest rate (adjusted for any deferred loan fees, costs, premium or discount) and assumes no dispositions, early prepayments or defaults. The Total Weighted Average Unleveraged Effective Yield is calculated based on the average of Unleveraged Effective Yield of all loans held by us as of
September 30, 2016
as weighted by the Outstanding Principal balance of each loan.
|
|
As of September 30, 2016
|
||||||
|
Carrying Amount
|
|
Outstanding Principal
|
||||
Total loans held for investment portfolio (excluding non-controlling interests held by third parties)
|
$
|
1,427,341
|
|
|
$
|
1,436,977
|
|
Non-controlling interest investment held by third parties
|
46,579
|
|
|
46,579
|
|
||
Loans held for investment
|
$
|
1,473,920
|
|
|
$
|
1,483,556
|
|
|
For the three months ended September 30, 2016
|
|
For the nine months ended September 30, 2016
|
||||
Interest income from loans held for investment, excluding non-controlling interests
|
$
|
19,473
|
|
|
$
|
54,573
|
|
Interest income from non-controlling interest investment held by third parties
|
1,303
|
|
|
3,882
|
|
||
Interest income from loans held for investment
|
$
|
20,776
|
|
|
$
|
58,455
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Net interest margin
|
$
|
11,758
|
|
|
$
|
12,242
|
|
|
$
|
32,497
|
|
|
$
|
37,545
|
|
Total expenses
|
3,918
|
|
|
3,506
|
|
|
10,599
|
|
|
10,310
|
|
||||
Income from continuing operations before income taxes
|
7,840
|
|
|
8,736
|
|
|
21,898
|
|
|
27,235
|
|
||||
Income tax expense (benefit), including excise tax
|
161
|
|
|
3
|
|
|
168
|
|
|
(15
|
)
|
||||
Net income from continuing operations
|
7,679
|
|
|
8,733
|
|
|
21,730
|
|
|
27,250
|
|
||||
Net income from operations of discontinued operations, net of income taxes
|
1,866
|
|
|
2,977
|
|
|
4,221
|
|
|
5,018
|
|
||||
Gain on sale of discontinued operations
|
10,196
|
|
|
—
|
|
|
10,196
|
|
|
—
|
|
||||
Net income attributable to ACRE
|
19,741
|
|
|
11,710
|
|
|
36,147
|
|
|
32,268
|
|
||||
Less: Net income attributable to non-controlling interests
|
(1,299
|
)
|
|
(2,331
|
)
|
|
(3,876
|
)
|
|
(6,860
|
)
|
||||
Net income attributable to common stockholders
|
$
|
18,442
|
|
|
$
|
9,379
|
|
|
$
|
32,271
|
|
|
$
|
25,408
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Interest income from loans held for investment
|
$
|
20,776
|
|
|
$
|
20,949
|
|
|
$
|
58,455
|
|
|
$
|
65,131
|
|
Interest expense
|
(9,018
|
)
|
|
(8,707
|
)
|
|
(25,958
|
)
|
|
(27,586
|
)
|
||||
Net interest margin
|
$
|
11,758
|
|
|
$
|
12,242
|
|
|
$
|
32,497
|
|
|
$
|
37,545
|
|
|
For the three months ended September 30,
|
|
For the nine months ended September 30,
|
||||||||||||
|
2016
|
|
2015
|
|
2016
|
|
2015
|
||||||||
Management and incentive fees to affiliate
|
$
|
1,690
|
|
|
$
|
1,351
|
|
|
$
|
4,380
|
|
|
$
|
4,040
|
|
Professional fees
|
678
|
|
|
617
|
|
|
1,703
|
|
|
1,535
|
|
||||
General and administrative expenses
|
690
|
|
|
698
|
|
|
2,099
|
|
|
2,144
|
|
||||
General and administrative expenses reimbursed to affiliate
|
860
|
|
|
840
|
|
|
2,417
|
|
|
2,591
|
|
||||
Total expenses
|
$
|
3,918
|
|
|
$
|
3,506
|
|
|
$
|
10,599
|
|
|
$
|
10,310
|
|
|
For the nine months ended September 30,
|
||||||
|
2016
|
|
2015
|
||||
Net income
|
$
|
36,147
|
|
|
$
|
32,268
|
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
(35,962
|
)
|
|
172,308
|
|
||
Net cash provided by (used in) operating activities
|
185
|
|
|
204,576
|
|
||
Net cash provided by (used in) investing activities
|
(242,456
|
)
|
|
197,259
|
|
||
Net cash provided by (used in) financing activities
|
275,044
|
|
|
(407,987
|
)
|
||
Change in cash and cash equivalents
|
$
|
32,773
|
|
|
$
|
(6,152
|
)
|
|
|
As of
|
|||||||||||||||||||||||||||
|
|
September 30, 2016
|
|
December 31, 2015
|
|
||||||||||||||||||||||||
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Interest Rate
|
|
Maturity Date
|
|
Total
Commitment |
|
Outstanding Balance
|
|
Interest Rate
|
|
Maturity Date
|
|
||||||||||||
Secured funding agreements:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Wells Fargo Facility
|
|
$
|
325,000
|
|
(1)
|
$
|
229,255
|
|
|
LIBOR+1.75 to 2.35%
|
|
December 14, 2017
|
(1)
|
$
|
225,000
|
|
|
$
|
101,473
|
|
|
LIBOR+1.75 to 2.35%
|
|
December 14, 2016
|
(1)
|
||||
Citibank Facility
|
|
250,000
|
|
(2)
|
319,925
|
|
|
LIBOR+2.00 to 2.50%
|
|
December 8, 2016
|
(2)
|
250,000
|
|
|
112,827
|
|
|
LIBOR+2.00 to 2.50%
|
|
December 8, 2016
|
(2)
|
||||||||
BAML Facility
|
|
125,000
|
|
(3)
|
77,679
|
|
|
LIBOR+2.25 to 2.75%
|
|
May 25, 2017
|
(3)
|
50,000
|
|
|
—
|
|
|
LIBOR+2.25 to 2.75%
|
|
May 26, 2016
|
(3)
|
||||||||
March 2014 CNB Facility
|
|
50,000
|
|
|
—
|
|
|
LIBOR+3.00%
|
|
March 11, 2017
|
(4)
|
50,000
|
|
|
—
|
|
|
LIBOR+3.00%
|
|
March 11, 2016
|
(4)
|
||||||||
July 2014 CNB Facility
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
(5)
|
75,000
|
|
|
66,200
|
|
|
LIBOR+3.00%
|
(5)
|
July 31, 2016
|
(5)
|
||||||
MetLife Facility
|
|
180,000
|
|
|
111,999
|
|
|
LIBOR+2.35%
|
|
August 12, 2017
|
(6)
|
180,000
|
|
|
109,474
|
|
|
LIBOR+2.35%
|
|
August 12, 2017
|
(6)
|
||||||||
April 2014 UBS Facility
|
|
140,000
|
|
|
82,004
|
|
|
LIBOR+1.88 to 2.28%
|
(7)
|
October 21, 2018
|
|
140,000
|
|
|
75,558
|
|
|
LIBOR+1.88 to 2.28%
|
(7)
|
October 21, 2018
|
|
||||||||
December 2014 UBS Facility
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
(8)
|
57,243
|
|
|
57,243
|
|
|
LIBOR+2.74%
|
|
July 6, 2016
|
|
||||||
U.S. Bank Facility
|
|
125,000
|
|
|
58,240
|
|
|
LIBOR+2.25%
|
|
July 31, 2019
|
(9)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
||||||
Subtotal
|
|
$
|
1,195,000
|
|
|
$
|
879,102
|
|
|
|
|
|
|
$
|
1,027,243
|
|
|
$
|
522,775
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Secured Term Loan
|
|
$
|
155,000
|
|
|
$
|
155,000
|
|
|
LIBOR+6.00%
|
(10)
|
December 9, 2018
|
|
$
|
155,000
|
|
|
$
|
75,000
|
|
|
LIBOR+6.00%
|
(10)
|
December 9, 2018
|
|
||||
Total
|
|
$
|
1,350,000
|
|
|
$
|
1,034,102
|
|
|
|
|
|
|
$
|
1,182,243
|
|
|
$
|
597,775
|
|
|
|
|
|
|
(1)
|
The maturity date of the master repurchase funding facility with Wells Fargo Bank, National Association (the “Wells Fargo Facility”) is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. Beginning on December 14, 2015, new advances under the Wells Fargo Facility accrue interest at a per annum rate equal to the sum of (i) 30 day LIBOR plus (ii) a pricing margin range of 1.75% to 2.35%. Advances on loans made prior to December 14, 2015 under the Wells Fargo Facility continue to accrue interest at a per annum rate equal to the sum of (i) 30 day LIBOR plus (ii) a pricing margin range of 2.00% to 2.50%. In June 2016, we amended the Wells Fargo Facility to, among other things, increase the size of the facility from $225.0 million to $325.0 million and extend the initial maturity date to December 14, 2017.
|
(2)
|
The Citibank Facility is subject to three 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. In July 2016, we entered into an amendment to the Citibank Facility, which added an accordion feature that provides for an increase in the $250.0 million commitment amount with respect to approved assets, as determined by Citibank, N.A. in its sole discretion.
|
(3)
|
In August 2016, we amended and restated the existing BAML Facility to increase its commitment size from $50.0 million to $125.0 million. Individual advances on loans under the BAML Facility generally have a two-year maturity, subject to a 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid.
|
(4)
|
We have one 12-month extension at our option provided that certain conditions are met and applicable extension fees are paid, which, if exercised, would extend the final maturity of the secured revolving funding facility with City National Bank (the “March 2014 CNB Facility”) to March 10, 2018.
|
(5)
|
The interest rate of the July 2014 CNB Facility was LIBOR plus 3.00%, comprised of LIBOR plus 1.50% and a credit support fee of 1.50% payable to Ares Management. In July 2016, we amended the July 2014 CNB Facility to extend the maturity date to September 30, 2016. On September 30, 2016, the July 2014 CNB Facility was repaid in full and its terms were not extended.
|
(6)
|
The revolving master repurchase facility with Metropolitan Life Insurance Company (the "MetLife Facility") is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid.
|
(7)
|
The price differential (or interest rate) on the revolving master repurchase facility with UBS Real Estate Securities Inc. (the “April 2014 UBS Facility”) is one-month LIBOR plus (i) 1.88% per annum, for assets that are subject to an advance for one year or less, (ii) 2.08% per annum, for assets that are subject to an advance in excess of one year but less than two years, and (iii) 2.28% per annum, for assets that are subject to an advance for more than two years; in each case, excluding amortization of commitment and exit fees.
|
(8)
|
The global master repurchase agreement with UBS AG (the “December 2014 UBS Facility,” and together with the April 2014 UBS Facility, the "UBS Facilities") has been repaid in full and its terms were not extended.
|
(9)
|
The U.S. Bank Facility is subject to two 12-month extensions at our option provided that certain conditions are met and applicable extension fees are paid. Advances under the U.S. Bank Facility accrue interest at a per annum rate of one-month LIBOR plus a spread of 2.25%, unless otherwise agreed between U.S. Bank and the Company, depending upon the mortgage loans sold to U.S. Bank in the applicable transaction.
|
(10)
|
The Secured Term Loan has a LIBOR floor of 1.0% on drawn amounts.
|
|
As of
|
||||||||||||||
|
September 30, 2016
|
|
December 31, 2015
|
||||||||||||
|
Carrying Amount
|
|
Outstanding Principal
|
|
Carrying Amount
|
|
Outstanding Principal
|
||||||||
Commercial mortgage-backed securitization debt (consolidated VIE)
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
61,815
|
|
|
$
|
61,856
|
|
Collateralized loan obligation securitization debt (consolidated VIE)
|
57,787
|
|
|
57,830
|
|
|
192,528
|
|
|
193,419
|
|
||||
Securitizations debt
|
$
|
57,787
|
|
|
$
|
57,830
|
|
|
$
|
254,343
|
|
|
$
|
255,275
|
|
Change in Average 30-Day LIBOR
|
|
For the three months ended September 30, 2016
|
|
For the nine months ended September 30, 2016
|
||||
Up 300 basis points
|
|
$
|
1.6
|
|
|
$
|
5.1
|
|
Up 200 basis points
|
|
$
|
1.0
|
|
|
$
|
3.4
|
|
Up 100 basis points
|
|
$
|
0.4
|
|
|
$
|
1.7
|
|
Down to 0 basis points
|
|
$
|
0.2
|
|
|
$
|
0.3
|
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid Per Share (1)
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Maximum (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
|
||||||
January 1, 2016 through January 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
20,000
|
|
|
February 1, 2016 through February 29, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
30,000
|
|
|
March 1, 2016 through March 31, 2016
|
|
34,854
|
|
|
$
|
10.28
|
|
|
34,854
|
|
|
$
|
29,642
|
|
April 1, 2016 through April 30, 2016
|
|
95,062
|
|
|
$
|
11.34
|
|
|
95,062
|
|
|
$
|
28,563
|
|
May 1, 2016 through May 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
June 1, 2016 through June 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
July 1, 2016 through July 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
August 1, 2016 through August 31, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
September 1, 2016 through September 30, 2016
|
|
—
|
|
|
—
|
|
|
—
|
|
|
$
|
28,563
|
|
|
Total
|
|
129,916
|
|
|
$
|
11.06
|
|
|
129,916
|
|
|
|
|
(1)
|
Amount includes expenses paid.
|
Exhibit
Number
|
|
Exhibit Description
|
||
2.1*
|
|
|
Purchase and Sale Agreement, among Ares Commercial Real Estate Corporation and Cornerstone Real Estate Advisers LLC. (1)
|
|
2.2*
|
|
|
Waiver and Amendment to Purchase and Sale Agreement, dated as of September 29, 2016, among Ares Commercial Real Estate Corporation and Barings Real Estate Advisers LLC (formerly known as Cornerstone Real Estate Advisers LLC).
|
|
3.1*
|
|
|
Articles of Amendment and Restatement of Ares Commercial Real Estate Corporation. (2)
|
|
3.2*
|
|
|
Amended and Restated Bylaws of Ares Commercial Real Estate Corporation. (3)
|
|
10.1*
|
|
|
Amendment No. 3 to Bridge Loan Warehousing Credit and Security Agreement dated as of May 26, 2016, among ACRC Lender B LLC and Bank of America, N.A. (4)
|
|
10.2*
|
|
|
Amendment No. 6 to Amended and Restated Master Repurchase and Securities Contract and Amended and Restated Guarantee Agreement dated as of June 30, 2016, among ACRC Lender W LLC, ACRC Lender W TRS LLC and Ares Commercial Real Estate Corporation and Wells Fargo Bank, National Association. (5)
|
|
10.3*
|
|
|
Amendment No. 5 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement, dated as of June 30, 2016, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto. (5)
|
|
10.4*
|
|
|
First Amendment to Master Repurchase Agreement and Guaranty dated as of July 13, 2016, among ACRC Lender C LLC, as borrower, Ares Commercial Real Estate Corporation, as guarantor, and Citibank, N.A., as lender. (7)
|
|
10.5*
|
|
|
Second Amendment to Master Repurchase Agreement and Guaranty dated as of July 13, 2016, among ACRC Lender C LLC, as borrower, Ares Commercial Real Estate Corporation, as guarantor, and Citibank, N.A., as lender. (6)
|
|
10.6*
|
|
|
Amendment No. 2 to Credit Agreement dated as of July 29, 2016, by and among ACRC Lender LLC, City National Bank, a national banking association, as arranger and administrative agent, and the lenders party thereto. (7)
|
|
10.7*
|
|
|
Amendment No. 6 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement dated as of July 29, 2016, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto. (7)
|
|
10.8*
|
|
|
Master Repurchase and Securities Contract dated as of August 1, 2016, between ACRC Lender US LLC and U.S. Bank National Association. (7)
|
|
10.9*
|
|
|
Payment Guaranty, dated as of August 1, 2016, by Ares Commercial Real Estate Corporation in favor of U.S. Bank National Association. (7)
|
|
10.10*
|
|
|
Amended and Restated Bridge Loan Warehousing Credit and Security Agreement, dated as of August 8, 2016, by and among ACRC Lender B LLC, Bank of America, N.A., as Administrative Agent and Lender and the other Lenders. (8)
|
|
10.11
|
|
|
Amendment to Guaranty, dated as of September 22, 2016, by Ares Commercial Real Estate Corporation, as guarantor, and Metropolitan Life Insurance Company, as buyer.
|
|
10.12
|
|
|
Amended No. 7 to Sixth Amended and Restated Mortgage Warehousing Credit and Security Agreement dated as of September 27, 2016, by and among ACRE Capital LLC, Bank of America, N.A., as Agent and Lender and the other Lenders party thereto.
|
|
31.1
|
|
|
Certification of Co-Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.2
|
|
|
Certification of Co-Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
31.3
|
|
|
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
32.1
|
|
|
Certification of Co-Chief Executive Officers and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS
|
|
|
XBRL Instance Document
|
|
101.SCH
|
|
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.LAB
|
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
101.DEF
|
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
(1)
|
Incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K (File No. 001-35517), filed on June 29, 2016.
|
(2)
|
Incorporated by reference to Exhibit 3.1 to the Company’s Form 10-K (File No. 001-35517), filed on March 1, 2016.
|
(3)
|
Incorporated by reference to Exhibit 3.2 to the Company’s Form S-8 (File No. 333-181077), filed on May 1, 2012.
|
(4)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on June 1, 2016.
|
(5)
|
Incorporated by reference to Exhibits 10.1 and 10.2, as applicable, to the Company’s Form 8-K (File No. 001-35517), filed on July 7, 2016.
|
(6)
|
Incorporated by reference to Exhibits 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on July 19, 2016.
|
(7)
|
Incorporated by reference to Exhibit 10.4, 10.6, 10.7, 10.8 and 10.9 to the Company’s Form 10-Q (File No. 001-35517), filed on August 4, 2016.
|
(8)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K (File No. 001-35517), filed on August 11, 2016.
|
|
ARES COMMERCIAL REAL ESTATE CORPORATION
|
|
|
|
|
|
|
|
Date: November 3, 2016
|
By
|
/s/ John Jardine
|
|
|
John Jardine
|
|
|
Co-Chief Executive Officer (Principal Executive Officer)
|
|
|
|
Date: November 3, 2016
|
By
|
/s/ Robert L. Rosen
|
|
|
Robert L. Rosen
|
|
|
Interim Co-Chief Executive Officer (Principal Executive Officer)
|
|
|
|
Date: November 3, 2016
|
By
|
/s/ Tae-Sik Yoon
|
|
|
Tae-Sik Yoon
|
|
|
Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)
|
1.
|
I have reviewed this Quarterly Report on Form
10-Q
of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ John Jardine
|
|
John Jardine
Co-Chief Executive Officer, Director and President
|
|
1.
|
I have reviewed this Quarterly Report on Form
10-Q
of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ Robert L. Rosen
|
|
Robert L. Rosen
Interim Co-Chief Executive Officer and Chairman
|
|
1.
|
I have reviewed this Quarterly Report on Form
10-Q
of Ares Commercial Real Estate Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
/s/ Tae-Sik Yoon
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer
|
|
1.
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
2.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ John Jardine
|
|
John Jardine
Co-Chief Executive Officer, Director and President
|
|
|
|
/s/ Robert L. Rosen
|
|
Robert L. Rosen
Interim Co-Chief Executive Officer and Chairman
|
|
|
|
/s/ Tae-Sik Yoon
|
|
Tae-Sik Yoon
Chief Financial Officer and Treasurer
|
|